Src Plays an Important Role in AGE-Induced Endothelial Cell Proliferation, Migration, and Tubulogenesis
Authors:
Open Access
- 21 June 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 9, 765
Abstract
Advanced glycation end products (AGEs), produced by the non-enzymatic glycation of proteins and lipids under hyperglycemia or oxidative stress conditions, has been implicated to be pivotal in the development of diabetic vascular complications, including diabetic retinopathy. We previously demonstrated that Src kinase played a causative role in AGE-induced hyper-permeability and barrier dysfunction in human umbilical vein endothelial cells (HUVECs). While the increase of vascular permeability is the early event of angiogenesis, the effect of Src in AGE-induced angiogenesis and the mechanism has not been completely revealed. Here, we investigated the impact of Src on AGE-induced HUVECs proliferation, migration, and tubulogenesis. Inhibition of Src with inhibitor PP2 or siRNA decreased AGE-induced migration and tubulogenesis of HUVECs. The inactivation of Src with pcDNA3/flag-SrcK298M also restrained AGE-induced HUVECs proliferation, migration, and tube formation, while the activation of Src with pcDNA3/flag-SrcY530F enhanced HUVECs angiogenesis alone and exacerbated AGE-induced angiogenesis. AGE-enhanced HUVECs angiogenesis in vitro was accompanied with the phosphorylation of ERK in HUVECs. The inhibition of ERK with its inhibitor PD98059 decreased AGE-induced HUVECs angiogenesis. Furthermore, the inhibition and silencing of Src suppressed the AGE-induced ERK activation. And the silencing of AGEs receptor (RAGE) inhibited the AGE-induced ERK activation and angiogenesis as well. In conclusions, this study demonstrated that Src plays a pivotal role in AGE-promoted HUVECs angiogenesis by phosphorylating ERK, and very likely through RAGE-Src-ERK pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81670076)
- Natural Science Foundation of Guangdong Province (S2013030013217)
This publication has 39 references indexed in Scilit:
- Role of Moesin in Advanced Glycation End Products-Induced Angiogenesis of Human Umbilical Vein Endothelial CellsScientific Reports, 2016
- Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseasesProgress in Retinal and Eye Research, 2014
- GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathwaysMetabolism, 2013
- Use of the mouse aortic ring assay to study angiogenesisNature Protocols, 2011
- Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid MalignanciesClinical Cancer Research, 2010
- A Src/Abl Kinase Inhibitor, SKI-606, Blocks Breast Cancer Invasion, Growth, and Metastasis In vitro and In vivoCancer Research, 2007
- Vascular Endothelial–Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult TissuesCirculation Research, 2005
- β2-Microglobulin modified with advanced glycation end products delays monocyte apoptosisKidney International, 2001
- V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.1997
- Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.Proceedings of the National Academy of Sciences, 1992